12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | August 08, 2023 01:31pm

Gainers

• Infinity Pharmaceuticals (NASDAQ:INFI) stock moved upwards by 60.9% to $0.14 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 108.7 million, which is 11458.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $12.9 million.
• Vivos Therapeutics (NASDAQ:VVOS) shares moved upwards by 59.0% to $0.41. The current volume of 64.5 million shares is 19105.0% of Vivos Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $12.4 million.
• Cardiff Oncology (NASDAQ:CRDF) stock rose 35.03% to $2.12. Trading volume for Cardiff Oncology's stock is 8.4 million as of 13:30 EST. This is 5382.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $94.7 million.
• Fresh2 Group (NASDAQ:FRES) stock rose 28.12% to $3.23. The market value of their outstanding shares is at $20.2 million.
• Tilray Brands (NASDAQ:TLRY) stock moved upwards by 27.59% to $2.83. Trading volume for this security as of 13:30 EST is 87.4 million, which is 444.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.9 billion.
• electroCore (NASDAQ:ECOR) shares moved upwards by 22.75% to $6.15. The current volume of 105.1K shares is 377.1% of electroCore's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $29.2 million.

Losers

• Vistagen Therapeutics (NASDAQ:VTGN) stock fell 37.7% to $8.13 during Tuesday's regular session. As of 13:30 EST, Vistagen Therapeutics's stock is trading at a volume of 7.5 million, which is 712.3% of its average full-day volume over the last 100 days. The company's market cap stands at $64.9 million.
• Mallinckrodt (AMEX:MNK) shares fell 21.83% to $1.42. The current volume of 7.7 million shares is 165.8% of Mallinckrodt's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $18.6 million.
• Tempest Therapeutics (NASDAQ:TPST) stock declined by 19.42% to $0.69. As of 13:30 EST, Tempest Therapeutics's stock is trading at a volume of 1.2 million, which is 1747.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.9 million.
• Arcturus Therapeutics (NASDAQ:ARCT) shares decreased by 19.25% to $25.72. The current volume of 775.0K shares is 179.2% of Arcturus Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $683.1 million. As per the news, the Q2 earnings report came out yesterday.
• Axogen (NASDAQ:AXGN) shares declined by 18.79% to $6.72. As of 13:30 EST, this security is trading at a volume of 2.9 million shares, making up 1609.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $288.6 million. As per the press release, Q2 earnings came out yesterday.
• FibroGen (NASDAQ:FGEN) shares declined by 18.65% to $1.44. The current volume of 5.3 million shares is 191.5% of FibroGen's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $140.5 million. The company's, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ARCT AXGN CRDF ECOR FGEN FRES INFI MNK TLRY TPST VTGN VVOS